← back to search

Edward F. Fritsch

Cancer Research Center ·
Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, and vaccines and immunoinformatics approaches.
h-index
29
citations
11,374
works
58
NIH funding
primary concept
Biology
email

Recent publications

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
Nature 2025cited by 153position: middledoi
Cancer vaccines: Building a bridge over troubled waters
Cell 2022cited by 309position: lastdoi
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Nature 2022cited by 186position: middledoi
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
Nature 2021cited by 537position: middledoi
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Nature Medicine 2021cited by 502position: middledoi
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Nature 2018cited by 1,415position: middledoi
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
Cancer Immunology Immunotherapy 2018cited by 139position: middledoi
Detecting neoepitope-specific intra-tumoral T cell responses in a glioblastoma patient treated with personal neoantigen vaccine
The Journal of Immunology 2018cited by 0position: middledoi
An immunogenic personal neoantigen vaccine for patients with melanoma
Nature 2017cited by 2,890position: middledoi
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Blood 2014cited by 306position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Catherine J. Wu · Dana-Farber/Harvard Cancer Center4 papers (2014–2022)Nir Hacohen · Broad Institute3 papers (2014–2018)Sachet A. Shukla · The University of Texas MD Anderson Cancer Center3 papers (2014–2018)Derin B. Keskin · Harvard University2 papers (2014–2018)Donna Neuberg · Massachusetts General Hospital2 papers (2014–2018)Annabelle Anandappa · Euroquality1 papers (2018–2018)Oriol Olive · Dana-Farber Cancer Institute1 papers (2018–2018)David S. DeLuca · Medizinische Hochschule Hannover1 papers (2014–2014)Ellese M. Carmona · Harvard University1 papers (2014–2014)Nathan D. Mathewson · Dana-Farber Cancer Institute1 papers (2018–2018)John Sidney · La Jolla Institute for Immunology1 papers (2014–2014)Kathleen M. Mahoney · Beth Israel Deaconess Medical Center1 papers (2018–2018)Patrick A. Ott · Harvard University1 papers (2018–2018)Kenneth J. Livak · Broad Institute1 papers (2018–2018)Apoorvi Chaudhri · The University of Texas Health Science Center at Houston1 papers (2018–2018)Kristian Cibulskis · Lypro Biosciences (United States)1 papers (2014–2014)Thomas Eisenhaure · Broad Institute1 papers (2018–2018)David A. Reardon · Massachusetts Institute of Technology1 papers (2018–2018)Stacey Gabriel · Broad Institute1 papers (2014–2014) · 1 papers (2018–2018)